Tet2-mutated myeloid progenitors possess aberrant in vitro self-renewal capacity.
Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Hiroyoshi
H
Kunimoto
Yumi
Y
Fukuchi
Masatoshi
M
Sakurai
Keiyo
K
Takubo
Shinichiro
S
Okamoto
Hideaki
H
Nakajima
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism; D049308:Dioxygenases; D016130:Immunophenotyping; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation; D023461:Myeloid Progenitor Cells / Q000378:metabolism*; D010641:Phenotype; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000378:metabolism
D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; D049308:Dioxygenases; C551914:Tet2 protein, mouse